Recruiting at 1 site No phase HIV/AIDS

HIV/AIDS study: Women SHINE

Official title Women SHINE: Addressing Syndemics and HIV Among Women Through Tech-Based Peer Engagement

ClinicalTrials.gov ID: NCT05509959

What this study is testing

What it's testing
The study will see if the program helps participants take their HIV medicine more consistently and reduces stress‑related symptoms like PTSD. It will also explore how factors such as coping skills and social support affect any changes.
Who it's for
Women living with HIV who have experienced adult interpersonal violence and have taken less than 90% of their HIV medicine in the past month.
What's involved
Participants are randomly assigned to either a four‑month program that includes one‑on‑one sessions with a peer navigator, phone/text check‑ins, weekly online support groups, and a resource website, or to a control group that gets one group session and the same website. All participants complete video surveys and mail in hair samples at the start and at 4, 8, and 12 months.
Time commitment
The study lasts about 12 months, with study visits (online surveys and hair sample mailing) at baseline, 4, 8, and 12 months, plus the four‑month intervention activities for those in the active arm.
  • Time commitment: about 4 weeks
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older, women only

You may be able to join if

  • Cisgender female
  • Diagnosis of HIV by a physician, healthcare provider, or community health worker
  • Aged 18 years or older
  • Speaking and reading English or Spanish
  • Adulthood experiences of interpersonal violence

You likely can't join if

  • Unwillingness to participate in the intervention
  • Transgender female
  • No diagnosis of HIV by a physician, healthcare provider, or community health worker
  • Aged less than 18 years
  • Not speaking and reading English or Spanish
  • Not currently prescribed ART
See the full eligibility criteria
Who can join
  • Cisgender female
  • Diagnosis of HIV by a physician, healthcare provider, or community health worker
  • Aged 18 years or older
  • Speaking and reading English or Spanish
  • Adulthood experiences of interpersonal violence
  • Currently prescribed ART
  • Self-report of \<90% past-month ART adherence
  • Not currently participating in another adherence intervention
  • Access to an internet browser
What rules you out
  • Unwillingness to participate in the intervention
  • Transgender female
  • No diagnosis of HIV by a physician, healthcare provider, or community health worker
  • Aged less than 18 years
  • Not speaking and reading English or Spanish
  • Not currently prescribed ART
  • Self-report of \>= 90% past-month ART adherence
  • Currently participating in another adherence intervention
  • No access to an internet browser
  • Cognitive impairment limiting the ability to provide informed consent
  • Experiencing only childhood experiences of interpersonal violence
  • Inability to safely participate in the study based on secondary screener

The study team makes the final eligibility decision.

Where it is enrolling

  • La Jolla, California, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The study runs about 4 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.

Who can join this trial?

This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at La Jolla, California, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.